MH

Ming Hsieh

Founder, Chairman of the Board, and Chief Executive Officer (CEO)

Fulgent Genetics

Fulgent Genetics Pipeline

DrugIndicationPhase
Nanoencapsulation & Targeted Therapy PlatformBroad range of cancersPre-clinical